| | | | | |
PLMK Plum Acquisition Corp. IV Class A Ordinary Shares | €9,1524 | -0,14% | €221,98M | €28,00K | |
DMAA Drugs Made In America Acquisition Corp. Ordinary Shares | €9,1351 | +0,05% | €221,87M | €1,13K | |
ERC Allspring Multi-Sector Income Fund | €7,8129 | -0,87% | €221,83M | €48,10K | |
GLO Clough Global Opportunities Fund | €5,1985 | -0,50% | €221,76M | €148,11K | |
NTWO Newbury Street II Acquisition Corp Class A Ordinary Shares | €9,1911 | +0,00% | €221,65M | €106,81 | |
TRGS TRG Latin America Acquisitions Corp. Class A Ordinary Shares | €8,5098 | +0,09% | €221,17M | €14,05K | |
CPZ Calamos Long/Short Equity & Dynamic Income Trust Common Stock | €11,0690 | -1,68% | €220,69M | €81,06K | |
| €3,2905 | -10,10% | €220,42M | €199,52K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,4385 | -6,18% | €220,23M | €609,69K | |
PNNT Pennant Investment Corp | €3,3732 | -1,36% | €219,92M | €600,25K | |
VNME Vendome Acquisition Corporation I Class A Ordinary Shares | €8,7906 | +0,15% | €219,65M | €199,84 | |
NUW Nuveen AMT-Free Municipal Value Fund | €12,0251 | -0,71% | €219,57M | €35,78K | |
| €32,8624 | -2,28% | €219,57M | €12,31K | |
DSP Viant Technology Inc. Class A Common Stock | €10,4574 | -13,30% | €219,37M | €365,94K | |
| €24,6016 | -1,72% | €219,27M | €43,98K | |
